Host responses to the pathogen Mycobacterium avium subsp. Paratuberculosis and beneficial microbes exhibit host sex specificity

Applied and Environmental Microbiology

Volumn 80, Issue 15, 2014, Pages 4481-4490

  Karunasena, Enusha ^a   McMahon, K Wyatt ^a   Chang, David ^b   Brashears, Mindy M ^c  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b Chenomx Inc   (Canada)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ENDOTHELIAL CELLS; HISTOLOGY; MACROPHAGES; MICROBIOLOGY; TISSUE; VOLATILE FATTY ACIDS;

EXPERIMENTAL CONDITIONS; EXPERIMENTAL GROUPS; GASTROINTESTINAL SYSTEMS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS; METABOLIC ACTIVITY; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; SHORT-CHAIN FATTY ACIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BACTERIA;

CYTOKINE; PROBIOTIC AGENT; VOLATILE FATTY ACID;

ANIMAL; BAGG ALBINO MOUSE; FEMALE; GASTROINTESTINAL TRACT; HOST RANGE; HUMAN; IMMUNOLOGY; LACTOBACILLUS; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; PHYSIOLOGY; SEX DIFFERENCE;

ANIMALS; CYTOKINES; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL TRACT; HOST SPECIFICITY; HUMANS; LACTOBACILLUS; MALE; MICE; MICE, INBRED BALB C; MICROBIOTA; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; PROBIOTICS; SEX FACTORS;

EID: 84904876370     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01229-14     Document Type: Article

References (64)

1. Yotis W, Stanke R. 1966. Bacteriostatic action of progesterone on staphylococci and other microorganisms. J. Bacteriol. 92:1285-1289.
2. Yotis WW. 1967. In vivo and in vitro action of norethindrone on staphylococci. J. Bacteriol. 94:1353-1358.
3. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. 2013. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339:1084-1088. http://dx.doi.org/10.1126/science.1233521.
4. Oertelt-Prigione S. 2012. The influence of sex and gender on the immune response. Autoimmun. Rev. 11:A479-A485. http://dx.doi.org/10.1016/j.autrev.2011.11.022.
5. Hughes GC, Clark EA. 2007. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 40: 470-481. http://dx.doi.org/10.1080/08916930701464764.
6. Bouman A, Heineman MJ, Faas MM. 2005. Sex hormones and the immune response in humans. Hum. Reprod. Update 11:411-423. http://dx.doi.org/10.1093/humupd/dmi008.
7. Panchanathan R, Duan X, Shen H, Rathinam VA, Erickson LD, Fitzgerald KA, Choubey D. 2010. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J. Immunol. 185:7385-7393. http://dx.doi.org/10.4049/jimmunol.1002468.
8. Panchanathan R, Shen H, Zhang X, Ho SM, Choubey D. 2010. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One 5:e10868. http://dx.doi.org/10.1371/journal.pone.0010868.
9. Fox HS, Bond BL, Parslow TG. 1991. Estrogen regulates the IFN-gamma promoter. J. Immunol. 146:4362-4367.
10. Marriott I, Huet-Hudson YM. 2006. Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 34:177-192. http://dx.doi.org/10.1385/IR:34:3:177.
11. Marriott I, Bost KL, Huet-Hudson YM. 2006. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J. Reprod. Immunol. 71:12-27. http://dx.doi.org/10.1016/j.jri.2006.01.004.
12. Garcia-Gomez E, Gonzalez-Pedrajo B, Camacho-Arroyo I. 2013. Role of sex steroid hormones in bacterial-host interactions. Biomed. Res. Int. 2013:928290. http://dx.doi.org/10.1155/2013/928290.
13. Hermon-Taylor J. 2009. Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario. Gut Pathog. 1:4757-4749. http://dx.doi.org/10.1186/1757-4749-1-15.
14. Harris NB, Barletta RG. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14:489-512. http://dx.doi.org/10.1128/CMR.14.3.489-512.2001.
15. Sartor RB. 2005. Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54:896-898. http://dx.doi.org/10.1136/gut.2004.055889.
16. Waters WR, Miller JM, Palmer MV, Stabel JR, Jones DE, Koistinen KA, Steadham EM, Hamilton MJ, Davis WC, Bannantine JP. 2003. Early induction of humoral and cellular immune responses during experimental Mycobacterium avium subsp. paratuberculosis infection of calves. Infect. Immun. 71:5130-5138. http://dx.doi.org/10.1128/IAI.71.9.5130-5138.2003.
17. Woo SR, Czuprynski CJ. 2008. Tactics of Mycobacterium avium subsp. paratuberculosis for intracellular survival in mononuclear phagocytes. J. Vet. Sci. 9:1-8. http://dx.doi.org/10.4142/jvs.2008.9.1.1.
18. Woo SR, Sotos J, Hart AP, Barletta RG, Czuprynski CJ. 2006. Bovine monocytes and a macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis. Vet. Immunol. Immunopathol. 110:109-120. http://dx.doi.org/10.1016/j.vetimm.2005.09.010.
19. Stabel JR, Ackermann MR. 2002. Temporal Mycobacterium paratuberculosis infection in T-cell receptor (TCR)-alpha and TCR-delta-deficient mice. Vet. Immunol. Immunopathol. 89:127-132. http://dx.doi.org/10.1016/S0165-2427(02)00167-8.
20. Motiwala AS, Janagama HK, Paustian ML, Zhu X, Bannantine JP, Kapur V, Sreevatsan S. 2006. Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes. Infect. Immun. 74:6046-6056. http://dx.doi.org/10.1128/IAI.00326-06.
21. Tremaroli V, Backhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489:242-249. http://dx.doi.org/10.1038/nature11552.
22. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258-1270. http://dx.doi.org/10.1016/j.cell.2012.01.035.
23. Baumgart DC, Sandborn WJ. 2007. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641-1657. http://dx.doi.org/10.1016/S0140-6736(07)60751-X.
24. Jones JL, Loftus EV, Jr. 2007. Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? Inflamm. Bowel Dis. 13:1299-1307. http://dx.doi.org/10.1002/ibd.20211.
25. Pierce ES. 2010. Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain? Gut Pathog. 2:21. http://dx.doi.org/10.1186/1757-4749-2-21.
26. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104:13780-13785. http://dx.doi.org/10.1073/pnas.0706625104.
27. Brashears MM, Amezquita A, Jaroni D. 2005. Lactic acid bacteria and their uses in animal feeding to improve food safety. Adv. Food Nutr. Res. 50:1-31. http://dx.doi.org/10.1016/S1043-4526(05)50001-9.
28. Karunasena E, Kurkure PC, Lackey RD, McMahon KW, Kiernan EP, Graham S, Alabady MS, Campos DL, Tatum OL, Brashears MM. 2013. Effects of the probiotic Lactobacillus animalis in murine Mycobacterium avium subspecies paratuberculosis infection. BMC Microbiol. 13:1471-2180. http://dx.doi.org/10.1186/1471-2180-13-8.
29. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M. 2011. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1): 4562-4569. http://dx.doi.org/10.1073/pnas.1000079107.
30. van Baarlen P, Wells JM, Kleerebezem M. 2013. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol. 34:208-215. http://dx.doi.org/10.1016/j.it.2013.01.005.
31. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, van Kooyk Y. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U. S. A. 105:19474-19479. http://dx.doi.org/10.1073/pnas.0810305105.
32. Christensen HR, Frokiaer H, Pestka JJ. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:171-178. http://dx.doi.org/10.4049/jimmunol.168.1.171.
33. R Development Core Team. 2014. R: a language and environment for statistical computing. R Development Core Team, Vienna, Austria.
34. Kerro Dego O, van Dijk JE, Nederbragt H. 2002. Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review. Vet. Q. 24:181-198. http://dx.doi.org/10.1080/01652176.2002.9695135.
35. Crepinsek MA, Crowe L, Michener K, Smart NA. 2012. Interventions for preventing mastitis after childbirth. Cochrane Database Syst. Rev. 10: CD007239. http://dx.doi.org/10.1002/14651858.CD007239.pub3.
36. Reyher KK, Haine D, Dohoo IR, Revie CW. 2012. Examining the effect of intramammary infections with minor mastitis pathogens on the acquisition of new intramammary infections with major mastitis pathogens-a systematic review and meta-analysis. J. Dairy Sci. 95:6483-6502. http://dx.doi.org/10.3168/jds.2012-5594.
37. Kellermayer R, Mir SA, Nagy-Szakal D, Cox SB, Dowd SE, Kaplan JL, Sun Y, Reddy S, Bronsky J, Winter HS. 2012. Microbiota separation and C-reactive protein elevation in treatment-naive pediatric granulomatous Crohn disease. J. Pediatr. Gastroenterol. Nutr. 55:243-250. http://dx.doi.org/10.1097/MPG.0b013e3182617c16.
38. Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP. 2013. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 11:868-875. http://dx.doi.org/10.1016/j.cgh.2013.02.015.
39. Knosel T, Schewe C, Petersen N, Dietel M, Petersen I. 2009. Prevalence of infectious pathogens in Crohn's disease. Pathol. Res. Pract. 205:223-230. http://dx.doi.org/10.1016/j.prp.2008.04.018.
40. Aziz NH. 2002. The role of chitinese of Serratia marcescens in controlling the production of zearalenone by Fusarium graminearum. Acta Microbiol. Pol. 51:131-137.
41. Holmes E, Li JV, Marchesi JR, Nicholson JK. 2012. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16:559-564. http://dx.doi.org/10.1016/j.cmet.2012.10.007.
42. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. 2012. Host-gut microbiota metabolic interactions. Science 336:1262-1267. http://dx.doi.org/10.1126/science.1223813.
43. Clark SE, Weiser JN. 2013. Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect. Immun. 81:392-401. http://dx.doi.org/10.1128/IAI.01168-12.
44. Gemayel R, Vinces MD, Legendre M, Verstrepen KJ. 2010. Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu. Rev. Genet. 44:445-477. http://dx.doi.org/10.1146/annurev-genet-072610-155046.
45. Snel B, Lehmann G, Bork P, Huynen MA. 2000. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 28:3442-3444. http://dx.doi.org/10.1093/nar/28.18.3442.
46. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ. 2013. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41:D808-D815. http://dx.doi.org/10.1093/nar/gks1094.
47. Fischbach MA, Sonnenburg JL. 2011. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 10:336-347. http://dx.doi.org/10.1016/j.chom.2011.10.002.
48. Bender RA. 2012. Regulation of the histidine utilization (hut) system in bacteria. Microbiol. Mol. Biol. Rev. 76:565-584. http://dx.doi.org/10.1128/MMBR.00014-12.
49. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W, Polonikov A, Peters A, Theis FJ, Meitinger T, Kronenberg F, Weidinger S, Wichmann HE, Suhre K, Wang-Sattler R, Adamski J, Illig T. 2011. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7:e1002215. http://dx.doi.org/10.1371/journal.pgen.1002215.
50. Bertram HC, Duus JO, Petersen BO, Hoppe C, Larnkjaer A, Schack-Nielsen L, Molgaard C, Michaelsen KF. 2009. Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to retrospective infant plasma parameters. Metabolism 58:1039-1045. http://dx.doi.org/10.1016/j.metabol.2009.03.011.
51. Qiao Q, Li T, Sun J, Liu X, Ren J, Fei J. 2011. Metabolomic analysis of normal (C57BL/6J, 129S1/SvImJ) mice by gas chromatography-mass spectrometry: detection of strain and gender differences. Talanta 85:718-724. http://dx.doi.org/10.1016/j.talanta.2011.04.060.
52. Sonnenburg ED, Sonnenburg JL, Manchester JK, Hansen EE, Chiang HC, Gordon JI. 2006. A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. Proc. Natl. Acad. Sci. U. S. A. 103:8834-8839. http://dx.doi.org/10.1073/pnas.0603249103.
53. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. 2011. Regulation of inflammation by short chain fatty acids. Nutrients 3:858-876. http://dx.doi.org/10.3390/nu3100858.
54. Carmeliet P. 2005. VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4-10. http://dx.doi.org/10.1159/000088478.
55. Arnold AP. 2009. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 21: 377-386. http://dx.doi.org/10.1111/j.1365-2826.2009.01831.x.
56. Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, White BA, Taneja V. 2012. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 7:e36095. http://dx.doi.org/10.1371/journal.pone.0036095.
57. Hogan AM, Collins D, Baird AW, Winter DC. 2009. Estrogen and its role in gastrointestinal health and disease. Int. J. Colorectal Dis. 24:1367-1375. http://dx.doi.org/10.1007/s00384-009-0785-0.
58. Klein SL. 2012. Immune cells have sex and so should journal articles. Endocrinology 153:2544-2550. http://dx.doi.org/10.1210/en.2011-2120.
59. O'Mahony F, Harvey BJ. 2008. Sex and estrous cycle-dependent rapid protein kinase signaling actions of estrogen in distal colonic cells. Steroids 73:889-894. http://dx.doi.org/10.1016/j.steroids.2008.01.021.
60. Kahl S, Elsasser TH, Li CJ. 2011. Modeling the effects of estradiol and progesterone on the acute phase proinflammatory axis: variability in tumor necrosis factor-alpha, nitric oxide, and xanthine oxidase responses to endotoxin challenge in steers. Domest. Anim. Endocrinol. 40:213-221. http://dx.doi.org/10.1016/j.domaniend.2011.01.003.
61. Kawano N, Koji T, Hishikawa Y, Murase K, Murata I, Kohno S. 2004. Identification and localization of estrogen receptor alpha-and betapositive cells in adult male and female mouse intestine at various estrogen levels. Histochem. Cell Biol. 121:399-405. http://dx.doi.org/10.1007/s00418-004-0644-6.
62. Araujo AB, Wittert GA. 2011. Endocrinology of the aging male. Best Pract. Res. Clin. Endocrinol. Metab. 25:303-319. http://dx.doi.org/10.1016/j.beem.2010.11.004.
63. Bested AC, Logan AC, Selhub EM. 2013. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part I-autointoxication revisited. Gut Pathog. 5:5. http://dx.doi.org/10.1186/1757-4749-5-5.
64. Bested AC, Logan AC, Selhub EM. 2013. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II-contemporary contextual research. Gut Pathog. 5:3. http://dx.doi.org/10.1186/1757-4749-5-3.